Epclusa approved for chronic hepatitis C
Tuesday, June 28, 2016 - 14:11
in Health & Medicine
HealthDay News The combination drug Epclusa has been approved by the U.S. Food and Drug Administration to treat the six major strains of chronic hepatitis C virus.